Skip to main content

Neuroprotection

  • Reference work entry
  • First Online:
Encyclopedia of Cancer
  • 95 Accesses

Definition

Neuroprotection is the active suppression of damaging neurotoxic conditions in the nervous system in an aim to inhibit apoptosis, neuronal dysfunction, and neurodegeneration of nerve cells. This may be either achieved by endogenous neuroprotectants or by exogenously added pharmacological agents/neuroprotective therapies. Neuroprotective therapies are currently clinically developed both for acute (e.g., stroke) and chronic forms of CNS damage (e.g., Alzheimer disease). In the context of cancer, neuroprotective strategies aim at limiting the often severe neurotoxic side effects of chemotherapy/radiotherapy without affecting the antitumor efficacy of antineoplastic therapies. In addition to the obvious benefits in the quality of life, this may also allow to delay premature termination of cancer treatment and thereby improve the clinical outcome.

Characteristics

Several chemotherapeutic agents are known to have severe neurotoxic activity, and peripheral neuropathy is one of the...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 2,499.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 3,999.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Buckingham SC, Campbell SL, Haas BR, Montana V, Robel S, Ogunrinu T, Sontheimer H (2011) Glutamate release by primary brain tumors induces epileptic activity. Nat Med 17:1269–1274

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schiff D, Wen PY, van den Bent MJ (2009) Neurological adverse effects caused by cytotoxic and targeted therapies. Nat Rev 6:596–603

    Google Scholar 

  • Walker M, Ni O (2007) Neuroprotection during chemotherapy: a systematic review. Am J Clin Oncol 30:82–92

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Donat Kögel .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Kögel, D. (2017). Neuroprotection. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46875-3_7153

Download citation

Publish with us

Policies and ethics